ST. LUKES SUGAR LAND HOSPITAL — History
CCN 670053 | 3-year financial timeline | COVID resilience: 30/100
🛡️ Public data only — no PHI permitted on this instance.
$85M
Latest Revenue (FY2022)
-2.1%
Revenue CAGR (3yr)
-24.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $89M | $89M | $85M | -4.6% | -2.1% |
| Operating Expenses | $91M | $103M | $105M | +1.8% | +7.6% |
| Operating Margin | -2.8% | -16.2% | -24.0% | -48.1% | +0.0% |
| Net Income | $-2M | $-14M | $-20M | -41.4% | +0.0% |
| Licensed Beds | 100 | 100 | 100 | +0.0% | +0.0% |
| Total Patient Days | 24,845 | 23,776 | 21,202 | -10.8% | -7.6% |
| Medicare Day % | 18% | 19% | 16% | -14.6% | -6.9% |
| Medicaid Day % | 9% | 12% | 14% | +13.8% | +25.3% |
COVID Impact & Recovery
Resilience Score: 30/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -4.1% ($89M → $85M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-2.1%
This Hospital
+7.6%
State Avg
Latest Margin
-24.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $83M | -34.7% |
| FY2024 (proj) | $81M | -45.3% |
| FY2025 (proj) | $79M | -55.9% |